Web NewDrugInformation.com

Inpersol-lc/lm W/ Dextrose 3.5% In Plastic Container Drug - Inpersol-lc/lm W/ Dextrose 3.5% In Plastic Container The trade name of the product as shown on the labeling. Dosage - SOLUTION; INTRAPERITONEAL The product dosage form and route separated by a semi-colon. Active Ingredient(s) - Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Multiple ingredients are in alphabetical order. Strength - 18.4MG/100ML;3.5GM/100ML;5.08MG/100ML;538MG/100ML;448MG/100ML The potency of the active ingredient(s), Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate. May repeat for multiple part products. Applicant - FRESENIUS The firm name holding legal responsibility for Inpersol-lc/lm W/ Dextrose 3.5% In Plastic Container. The firm name is condensed to a maximum twenty character unique string. New Drug Application (NDA) Number - 020374 The FDA assigned number to Inpersol-lc/lm W/ Dextrose 3.5% In Plastic Container. Format is nnnnnn. Product Number - 003 The FDA assigned number to identify Inpersol-lc/lm W/ Dextrose 3.5% In Plastic Container. Each strength is a separate product. May repeat for multiple part products. Format is nnn. Therapeutic Equivalence (TE) Code - AT The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products. Approval Date - Jun 13, 1994 The date Inpersol-lc/lm W/ Dextrose 3.5% In Plastic Container was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982". Reference Listed Drug (RLD) - No The pioneer or innovator of Inpersol-lc/lm W/ Dextrose 3.5% In Plastic Container. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No. Type - RX The group or category of approved drugs Inpersol-lc/lm W/ Dextrose 3.5% In Plastic Container is in. Format is RX, OTC, DISCN. Applicant Full Name - Fresenius Usa Inc The full name of the firm holding legal responsibility for the new application of Inpersol-lc/lm W/ Dextrose 3.5% In Plastic Container. Inpersol-lc/lm W/ Dextrose 3.5% In Plastic Container Dianeal Pd-2 W/ Dextrose 4.25% In Plastic Container 25.7mg/100ml;4.25gm/100ml;5.08mg/100ml;538mg/100ml;448mg/100ml Solution; Intraperitoneal Inpersol-lc/lm W/ Dextrose 1.5% In Plastic Container 18.4mg/100ml;1.5gm/100ml;5.08mg/100ml;538mg/100ml;448mg/100ml Solution; Intraperitoneal Inpersol-lc/lm W/ Dextrose 2.5% In Plastic Container 18.4mg/100ml;2.5gm/100ml;5.08mg/100ml;538mg/100ml;448mg/100ml Solution; Intraperitoneal Inpersol-lc/lm W/ Dextrose 3.5% In Plastic Container 18.4mg/100ml;3.5gm/100ml;5.08mg/100ml;538mg/100ml;448mg/100ml Solution; Intraperitoneal Dianeal Pd-2 W/ Dextrose 1.5% In Plastic Container 18.3mg/100ml;1.5gm/100ml;5.08mg/100ml;538mg/100ml;448mg/100ml Solution; Intraperitoneal Dianeal Pd-2 W/ Dextrose 1.5% In Plastic Container 25.7mg/100ml;1.5gm/100ml;5.08mg/100ml;538mg/100ml;448mg/100ml Solution; Intraperitoneal Dianeal Pd-2 W/ Dextrose 2.5% In Plastic Container 25.7mg/100ml;2.5gm/100ml;5.08mg/100ml;538mg/100ml;448mg/100ml Solution; Intraperitoneal Dianeal Pd-2 W/ Dextrose 2.5% In Plastic Container 25.7mg/100ml;2.5gm/100ml;5.08mg/100ml;538mg/100ml;448mg/100ml Solution; Intraperitoneal Dianeal Pd-2 W/ Dextrose 3.5% In Plastic Container 25.7mg/100ml;3.5gm/100ml;5.08mg/100ml;538mg/100ml;448mg/100ml Solution; Intraperitoneal Dianeal Pd-2 W/ Dextrose 4.25% In Plastic Container 25.7mg/100ml;4.25gm/100ml;5.08mg/100ml;538mg/100ml;448mg/100ml Solution; Intraperitoneal NewDrugInformation